Skip to content
PICO Portalanswers from OpenAlex

Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia

PaperCitations, authors & open-access status

Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia is a paper indexed in PICO Portal from OpenAlex.

How many citations does Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia have?

PICO Portalcitation count

Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia has 29 citations in the OpenAlex counts PICO Portal stores.

When was Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia published?

PICO Portalyear

Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia has 2019 year in the PICO Portal index.

What is the open-access status of Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia?

PICO Portaloa status

Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia has gold oa status in the PICO Portal index.

What is the DOI of Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia?

PICO Portaldoi

The DOI for Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia is on the source record.

What is the PMID of Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia?

PICO Portalpmid

The PMID for Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia is on the source record.

What is the OpenAlex record for Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia?

PICO Portalopenalex

The OpenAlex for Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial